Triad Isotopes PET Drugs Earn FDA Approval

The U.S. Food and Drug Administration (FDA) has approved Triad Isotopes' Abbreviated New Drug Applications (ANDA) for two PET radiopharmaceuticals: Fludeoxyglucose F18 (¹⁸F FDG), which is indicated for positron emission tomography (PET) imaging in Oncology, Cardiology and Neurology; and Sodium Fluoride F-18, which is indicated for imaging bone to define areas of altered osteogenic activity.  For more information, see the package inserts and important safety information below.